MirimGENE is Drug Discovery in South Korea that focus on high mortality business. Founded in 2019. They cover business area such as developer, personalized precision medicine, infectious disease, innovative new drug, no treatment, high mortality, intractable immune disease, exist drug, medical practitioner, patient, exist treatment.
2019
( 5 years old in 2024 )
High Mortality
-
Number 204 POSCO Green Building
Yonsei University Songdo Campus
Incheon
South Korea
Private
developerpersonalized precision medicineinfectious diseaseinnovative new drugno treatmenthigh mortalityintractable immune diseaseexist drugmedical practitionerpatientexist treatment
* We use standard office opening hours in near MirimGENE's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
MirimGENE is Drug Discovery business from South Korea that founded in 2019 (5 years old in 2024), MirimGENE business is focusing on High Mortality.
MirimGENE headquarter office and corporate office address is located in Number 204 POSCO Green Building Yonsei University Songdo Campus Incheon South Korea.
MirimGENE was founded in South Korea.
In 2024, MirimGENE is currently focus on high mortality sector.
Above is snippet of Google Trends for "high mortality" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with MirimGENE, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
